Detail page

Knowledge Web

Person

Martin Bornhäuser (1966-)

Arzt

Name	Martin Bornhäuser
Time	1966- (Date of birth and death)
Place	Dresden (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Onkologe Hochschullehrer
Further information	Professor für Hämatologie, Onkologie Vorsitzender Tumorzentrum Dresden (TZ) Geschäftsführender Direktor Nationales Centrum für Tumorerkrankungen Standort Dresden (NCT Dresden)
Source	http://stemcell-lab-mk1dresden.de/wordpress/forschung/prof-dr-martin-bornhaeuser/ (Stand: 21.09.2018)
Record type	Person
GND-Identifier	1167559118
Record ID	1167559118
Involved in show all Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients A Self-Assembled Matrix System for Cell-Bioengineering Applications in Different Dimensions, Scales, and Geometries Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa) Distress in soft‐tissue sarcoma and gastrointestinal stromal tumours patients - Results of a German multicentre observational study (PROSa) Functional analyses of extremely premature baboon lung-derived MSCs after prophylactic cell therapy administration Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations Regulation of Proliferation of Alveolar Macrophages in Acute Respiratory Distress Syndrome The role of CD105 deficiency on the bone marrow vasculature : a time-lapse analysis Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study Application of mathematical modelling to describe and predict treatment dynamics in patients with NPM1-mutated Acute Myeloid Leukaemia (AML) Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study Bidirectional interference of mesenchymal stromal cells and anti-leukemic effector cells within the bone marrow microenvironment Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa) Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels = Die Rolle von Galectin-9 im duktalen Adenokarzinom des Pankreas Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study Financial toxicity in sarcoma patients and survivors in Germany : results from the multicenter PROSa study High mortality of COVID-19 early after allogeneic stem cell transplantation: a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Impaired overall survival in young patients with acute myeloid leukemia and variants in genes predisposing for myeloid malignancies Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT Targeting the leukemic stem cell niche : An opportunity for novel therapeutic treatment options Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study Autologe periphere Blutstammzelltransplantation beim Hodgkin- oder Mantelzelllymphom : Einfluss von Patienten-, Krankheits- und Behandlungscharakteristika auf die Therapieergebnisse Functional screening of primary DNMT3A-mutant AML cells in search for new therapeutic targets Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: cross-sectional results of a German multicentre observational study (PROSa) Vorkommen, Verteilung und klinische Relevanz tumorinfiltrierender 6-sulfo LacNAc+ Monozyten und plasmazytoider dendritischer Zellen im humanen Kolonkarzinom Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial Association of country-specific socioeconomic factors with survival of patients who experience severe classic acute graft-vs.-host disease after allogeneic hematopoietic cell transplantation : : an analysis from the transplant complications working party of the EBMT Auftreten und Kinetik falschpositiver Candida- und Aspergillus- Antigentests nach Applikation parenteraler Ernährung und Piperacillin-Tazobactam bei Patienten auf einer hämatologisch-onkologischen Station Die Auswirkungen des Coronin-1a-Genknockouts auf die späten Erkrankungsphasen der nephrotoxischen Halbmondnephritis in der Maus The health-related quality of life of sarcoma patients and survivors in Germany - cross-sectional results of a nationwide observational study (PROSa) The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of a Nationwide Observational Study (PROSa) Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents — a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin’s Lymphoma Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Volumenänderungen der Unterarmmuskulatur bei statischer Belastung : eine Untersuchung über Trainingseinflüsse an Windsurfern der Nationalmannschaft

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Martin Bornhäuser (1966-)

Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients

A Self-Assembled Matrix System for Cell-Bioengineering Applications in Different Dimensions, Scales, and Geometries

Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients

Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa)

Distress in soft‐tissue sarcoma and gastrointestinal stromal tumours patients - Results of a German multicentre observational study (PROSa)

Functional analyses of extremely premature baboon lung-derived MSCs after prophylactic cell therapy administration

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

Regulation of Proliferation of Alveolar Macrophages in Acute Respiratory Distress Syndrome

The role of CD105 deficiency on the bone marrow vasculature : a time-lapse analysis

Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study

Application of mathematical modelling to describe and predict treatment dynamics in patients with NPM1-mutated Acute Myeloid Leukaemia (AML)

Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study

Bidirectional interference of mesenchymal stromal cells and anti-leukemic effector cells within the bone marrow microenvironment

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa)

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries

Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels = Die Rolle von Galectin-9 im duktalen Adenokarzinom des Pankreas

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Financial toxicity in sarcoma patients and survivors in Germany : results from the multicenter PROSa study

High mortality of COVID-19 early after allogeneic stem cell transplantation: a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Impaired overall survival in young patients with acute myeloid leukemia and variants in genes predisposing for myeloid malignancies

Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies

Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

Targeting the leukemic stem cell niche : An opportunity for novel therapeutic treatment options

Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study

Autologe periphere Blutstammzelltransplantation beim Hodgkin- oder Mantelzelllymphom : Einfluss von Patienten-, Krankheits- und Behandlungscharakteristika auf die Therapieergebnisse

Functional screening of primary DNMT3A-mutant AML cells in search for new therapeutic targets

Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: cross-sectional results of a German multicentre observational study (PROSa)

Vorkommen, Verteilung und klinische Relevanz tumorinfiltrierender 6-sulfo LacNAc+ Monozyten und plasmazytoider dendritischer Zellen im humanen Kolonkarzinom

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial

Association of country-specific socioeconomic factors with survival of patients who experience severe classic acute graft-vs.-host disease after allogeneic hematopoietic cell transplantation : : an analysis from the transplant complications working party of the EBMT

Auftreten und Kinetik falschpositiver Candida- und Aspergillus- Antigentests nach Applikation parenteraler Ernährung und Piperacillin-Tazobactam bei Patienten auf einer hämatologisch-onkologischen Station

Die Auswirkungen des Coronin-1a-Genknockouts auf die späten Erkrankungsphasen der nephrotoxischen Halbmondnephritis in der Maus

The health-related quality of life of sarcoma patients and survivors in Germany - cross-sectional results of a nationwide observational study (PROSa)

The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of a Nationwide Observational Study (PROSa)

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents — a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin’s Lymphoma

Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Volumenänderungen der Unterarmmuskulatur bei statischer Belastung : eine Untersuchung über Trainingseinflüsse an Windsurfern der Nationalmannschaft